Biography

Prof Tony Hu is a world-renowned expert in biomedical engineering, nanotechnology, and point-of-care diagnostics. He serves as the Dean of School of Biomedical Engineering at Tsinghua University. His research focuses on developing innovative nanotechnology-based approaches for disease diagnosis and treatment monitoring, with particular emphasis on extracellular vesicles, CRISPR-based diagnostics, and tuberculosis detection.

Prof Hu has published extensively in top-tier scientific journals including Nature Biomedical Engineering, Nature Nanotechnology, Nature Communications, Science Translational Medicine, The Lancet Microbe, and PNAS. His work has been highlighted by New England Journal of Medicine and Nature Reviews. He has developed multiple breakthrough technologies for rapid, low-cost disease diagnosis suitable for resource-limited settings.

His research group pioneered the use of nanoplasmonic sensors, CRISPR-Cas systems, and extracellular vesicle-based assays for detecting pathogens including Mycobacterium tuberculosis, SARS-CoV-2, and HIV. His work bridges the gap between laboratory research and clinical applications, with a strong focus on addressing global health challenges.